Oversold Signals Emerge in Large-Cap Stocks
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 01 2026
0mins
Should l Buy DG?
Source: seekingalpha
- Oversold Stock List: The Relative Strength Index (RSI) screening highlights Sysco Corporation (SYY) at the top with an RSI of 24, indicating significant oversold signals and a market capitalization of $34.11 billion, suggesting potential undervaluation and rebound opportunities.
- Sector Distribution: Following closely is Boston Scientific Corporation (BSX) with an RSI of 25 and a market cap of $93.26 billion, reflecting intense selling pressure across sectors such as healthcare and consumer staples, which may present value investment opportunities for investors.
- Other Notable Oversold Stocks: McCormick & Company (MKC), Cintas Corporation (CTAS), and Universal Health Services (UHS) rank in the top five with RSI values of 26 and 27, and market caps of $13.54 billion, $67.66 billion, and $10.93 billion respectively, highlighting their vulnerability in the current market environment.
- Market Pressure Analysis: All stocks in the top ten list maintain an RSI below 30, indicating high selling pressure across sectors including medical facilities, retail, and real estate, prompting investors to monitor these oversold stocks for potential rebound opportunities amidst market volatility.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DG
Wall Street analysts forecast DG stock price to rise
16 Analyst Rating
9 Buy
7 Hold
0 Sell
Moderate Buy
Current: 121.210
Low
125.00
Averages
147.00
High
170.00
Current: 121.210
Low
125.00
Averages
147.00
High
170.00
About DG
Dollar General Corporation is a discount retailer. The Company offers merchandise, including consumable items, seasonal items, home products and apparel. Its merchandise includes brands from manufacturers, as well as its own private brand selections with prices at discounts to brands. Its consumables category includes paper and cleaning products, packaged food, perishables, snacks, health and beauty, pet, and tobacco products. Its seasonal products include holiday items, toys, batteries, small electronics, greeting cards, stationery, prepaid phones and accessories, gardening supplies, hardware, automotive and home office supplies. Its home products include kitchen supplies, cookware, small appliances, light bulbs, storage containers, frames, candles, craft supplies and kitchen, bed and bath soft goods. The Company’s apparel products include basic items for infants, toddlers, girls, boys, women and men, as well as socks, underwear, disposable diapers, shoes and accessories.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Market Weakness: The S&P 500 index showed significant weakness as President Trump's deadline for Iran approached, with most of the session in the red, reflecting investor concerns over economic prospects amid declining consumer confidence and rising inflation.
- Retail Sector Decline: Walmart's 3.3% drop indicates that even budget-conscious consumers may cut back on spending during an economic downturn, suggesting a deteriorating overall consumer health that could have long-term implications for the retail sector.
- Cruise Industry Struggles: Shares of Royal Caribbean, Norwegian Cruise Line, and Carnival fell nearly 3%, 3.3%, and 2.96% respectively, indicating a potential decline in consumer demand for travel post-pandemic, which raises further concerns about economic recovery.
- Pharmaceutical Stocks Underperform: Merck, Pfizer, and AbbVie saw declines of 1.3%, 2.6%, and 0.2%, respectively, highlighting inflationary pressures and the dual challenges of economic slowdown and rising costs faced by the pharmaceutical industry.
See More
- Dividend Yield Analysis: Dollar General's current annualized dividend yield stands at 1.93%, and while dividends are not always predictable, historical data suggests this yield may remain stable going forward, appealing to income-seeking investors.
- Stock Price Range: Over the past 52 weeks, Dollar General's stock has seen a low of $84.70 and a high of $158.23, with the latest trading price at $122.66, indicating stability within this range that may influence investor buying decisions.
- ETF Composition: According to ETF Finder, Dollar General constitutes 8.60% of the AGF U.S. Market Neutral Anti-Beta Fund ETF (Symbol: BTAL), highlighting its significance in related portfolios and potentially impacting the overall performance of the fund.
- Intraday Trading Performance: On Monday, Dollar General shares rose approximately 2%, reflecting positive market sentiment towards the stock, which may attract more investors to consider its future growth potential.
See More
- Easter Spending Trends: According to the National Retail Federation, consumer spending for Easter is projected to reach a record high of $24.9 billion in 2026, with food expenditures accounting for $7.5 billion, indicating increased financial pressure on consumers during the holiday.
- Rising Food Prices: Economist Bob McNab highlighted that the pain point for Easter spending stems from rising prices, as consumers will face significantly higher costs if they aim to purchase the same items as last year, reflecting inflation's impact on household budgets.
- Dollar General's Market Expansion: Over the past few years, Dollar General has actively expanded its grocery offerings, stating in 2023 that it provides fresh fruits and vegetables in more locations than any other mass retailer, becoming a key food supplier in rural and underserved areas, thus helping to reduce food deserts.
- New CEO Appointment: Dollar General announced the appointment of JJ Fleeman as the new CEO in 2027, who previously held an executive position at Ahold Delhaize, signaling the company's intent to further expand its grocery business and enhance its competitive position in the market.
See More
- Retail Sales Growth: U.S. retail sales rose 0.6% in February compared to the previous month, surpassing the expected 0.4% growth, indicating broad consumer spending increases in discretionary categories like department stores, restaurants, and cars, despite ongoing recession concerns.
- Impact of Energy Prices: The Iran war has led to a one-third increase in oil prices, raising fuel and shipping costs, prompting investors to seek safe investment avenues, with consumer staples stocks favored for their defensive and recession-resistant characteristics.
- Dollar General Performance: Dollar General has a strong track record during economic downturns, with management noting a shift in consumer behavior due to high energy prices and inflation, anticipating comparable sales and profit growth in 2025 as it continues to expand and renovate stores.
- Philip Morris Growth: Philip Morris International has pivoted successfully to next-gen products like Zyn and Iqos, achieving a 6.5% organic revenue growth to $40.6 billion, with a solid 3.7% dividend yield, positioning it well to weather market volatility amid the Iran conflict.
See More
- Oversold Stock List: The Relative Strength Index (RSI) screening highlights Sysco Corporation (SYY) at the top with an RSI of 24, indicating significant oversold signals and a market capitalization of $34.11 billion, suggesting potential undervaluation and rebound opportunities.
- Sector Distribution: Following closely is Boston Scientific Corporation (BSX) with an RSI of 25 and a market cap of $93.26 billion, reflecting intense selling pressure across sectors such as healthcare and consumer staples, which may present value investment opportunities for investors.
- Other Notable Oversold Stocks: McCormick & Company (MKC), Cintas Corporation (CTAS), and Universal Health Services (UHS) rank in the top five with RSI values of 26 and 27, and market caps of $13.54 billion, $67.66 billion, and $10.93 billion respectively, highlighting their vulnerability in the current market environment.
- Market Pressure Analysis: All stocks in the top ten list maintain an RSI below 30, indicating high selling pressure across sectors including medical facilities, retail, and real estate, prompting investors to monitor these oversold stocks for potential rebound opportunities amidst market volatility.
See More
- Major Partnership Agreement: Nebius has signed a $27 billion AI infrastructure deal with Meta Platforms, ensuring that Meta secures sufficient computing power over the next five years to support its AI model development, showcasing Nebius's strong competitive position in the AI cloud computing sector.
- Market Validation: The deal's value exceeds Nebius's previous company valuation, marking a significant recognition of its status as an emerging cloud provider and proving the viability of its business model, which attracts increased investor interest.
- Technological Investment: Nebius will provide Meta with $12 billion worth of computing capacity using Nvidia's latest Vera Rubin chips, a technological choice that will significantly enhance Meta's competitiveness in the AI space, ensuring it stays ahead in technological advancements.
- Strategic Expansion: This agreement not only deepens the collaboration between Nebius and Meta but also complements other significant investments from Nvidia and Microsoft, further solidifying Nebius's critical role in the global AI infrastructure market.
See More











